Table 2.
Cell no. | Year | Country | Cell name | Diagnosis | Isolation source | Digestion method | Sorting method | Maintenance medium | Cell morphology | Doubling time | References |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2001 | Republic of Korea | Choi-CK | IHCCA | Primary tumor | No digestion | Differential trypsinization, scraping, or G418 treatment (100 μg/mL) | Opti-MEM + 10% FBS + 30 mmol/L sodium bicarbonate + antibiotics | Polygonal and compact cells with indistinct cell boundaries | — | 75 |
2 | Cho-CK | Polygonal and compact cells with indistinct cell boundaries | |||||||||
3 | JCK | Polygonal morphology and some spindle-shaped cells | |||||||||
4 | SCK | Monolayer, epithelioid or spindle-shaped cells; fewer polygonal shaped cells | |||||||||
5 | 2002 | Thailand | HubCCA-1 | IHCCA | Intrahepatic biliary fluid | — | — | Ham's F12 + 20% FBS + P/S | Adherent, monolayer, polygonal to spindle-shaped cells | — | 76,77 |
6 | 2002 | Thailand | KKU-100 | IHCCA | Primary tumor | 0.025% trypsin-EDTA, 37°C, 1 hour | Fibroblasts removed with a cell scraper and by differential trypsinization | Ham's F12 + 20% FBS + P/S | Compact, polygonal to spindle-shaped cells; floating or clumping in a confluent monolayer; large nucleus containing two to five nucleoli and a clear cytoplasm | 72 hours | 77,78 |
7 | 2002 | Republic of Korea | SNU-245 | EHCCA | Primary tumor | No digestion | Differential trypsinization used to remove fibroblasts | RPMI 1640 + 10% FBS | Monolayer, adherent cells; trabecular arrangement with acinar formation | 54 hours | 79 |
8 | SNU-1079 | IHCCA | Monolayer, adherent cells; pleomorphic appearance with multiple cytoplasmic processes; numerous cytoplasmic vacuoles in some cells; some multinucleated cells | 72 hours | |||||||
9 | SNU-1196 | EHCCA | Monolayer, adherent cells; trabecular pattern consisted of spindle to polygonal shaped cells having vesicular nuclei and multiple small nucleoli | 48 hours | |||||||
10 | 2004 | Japan | TKKK | IHCCA | — | — | — | DMEM (low glucose) + 10% FBS | Adherent, monolayer, epithelial-like cells; pavement-like proliferation | — | 80 |
11 | 2005 | Thailand | KKU-M055 | IHCCA | — | — | — | Ham's F-12 + 10% FBS + P/S | — | — | 81 |
12 | KKU-OCA17 | ||||||||||
13 | 2005 | Japan | TBCN6 | EHCCA | Xenograft | 0.25% trypsin in PBS, 37°C, 10 minutes | — | DMEM + 10% FBS | Adherent, monolayer, polygonal cells | 38 hours | 82 |
14 | TGBC-47 | ||||||||||
15 | 2006 | Thailand | KKU-M139 | CCA | Primary tumor | — | — | Ham's F12 or RPMI 1640 + 10% FBS + P/S | Adherent, monolayer, polygonal cells; pavement-like proliferation | 17 hours | 16,76 |
16 | 2006 | Thailand | RMCCA-1 | IHCCA | Primary tumor | No digestion | Differential trypsinization used to remove fibroblasts | Ham's F12 + 20% FBS + EGF + 250 μg/mL amphotericin + P/S | Circular to spindle shape with many processes and ornamental fringes; granulated nucleus and cytoplasm | 48 hours | 83 |
17 | 2007 | China | HKGZ-CC | IHCCA | Primary tumor | 1200–2000 U/mL collagenase and DNase in 10 mL/g DPBS | — | DMEM | Adherent, monolayer, epithelial-like cells | 48 hours | 84 |
18 | 2007 | Japan | IHGGK | IHCCA | — | — | — | RPMI 1640 + 10% FBS + P/S | Adherent, monolayer, epithelial-like cells | 85, http://www2.idac.tohoku.ac.jp/dep/ccr/TKGdate/TKGvo106/0623.html, last accessed May 5, 2022 | |
19 | 2009 | Thailand | CL-2 | CCA | — | — | — | DMEM + 15% FBS + P/S | — | — | 86,87 |
20 | CL-6 | ||||||||||
21 | CL-19 | ||||||||||
22 | 2010 | Japan | NCC-BD1 | EHCCA | Xenograft | No digestion | Fibroblasts removed by mechanical scraping | RPMI 1640 + 10% FBS + 2 mmol/L l-glutamine + P/S | Adherent, monolayer, epithelial-like cells; pavement-like proliferation | — | 88 |
23 | NCC-BD2 | EHCCA | |||||||||
24 | NCC-CC1 | IHCCA | |||||||||
25 | NCC-CC3-1 | IHCCA | |||||||||
26 | NCC-CC3-2 | IHCCA | |||||||||
27 | NCC-CC4-1 | IHCCA | |||||||||
28 | 2013 | China | HCCC-9810 | IHCCA | — | — | — | RPMI 1640 + 10% FBS + P/S | — | 20 hours | 89 |
29 | 2015 | Italy | MT-CHC01 | IHCCA | Xenograft | 200 U/mL collagenase, 3 hours, 37°C | — | Knockout/DMEM/F-12 + 10% FBS + P/S | Monolayer, adherent cells | 40 hours | 90 |
30 | 2016 | USA | ICC1 | IHCCA | — | Trypsin, 30 minutes, 37°C | — | RPMI or DMEM/F12 + 5% FBS + P/S | — | 91 | |
31 | ICC2 | ||||||||||
32 | ICC5 | ||||||||||
33 | 2016 | China | ZJU-0826 | EHCCA | Primary tumor | — | Fibroblasts eliminated by differential trypsinization and differential attachment | RPMI 1640 + 10% FBS + antibiotics | Monolayer, adherent, homogeneous cells with characteristic loose pleomorphic cells and rare multinucleated cells | 63 hours | 92 |
34 | ZJU-1125 | IHCCA | Monolayer, epithelial-like, adherent cells; polygonal, occasionally multinucleated | 44 hours | |||||||
35 | 2017 | Germany | CCC-5 | EHCCA | Pleural effusion | No digestion | — | DMEM + 20% FBS: KFSM - 2:1 | Monolayer, spindle- to polygonal shaped cells, pavement-like proliferation; anaplastic, multinucleated giant cells | 60 hours | 93 |
36 | 2017 | Thailand | KKU-023 | IHCCA | Primary tumor | 1 mg/mL collagenase, 37°C, 30–45 minutes | Fibroblasts aseptically removed with a cell scraper | Ham's F12 + 10% FBS + P/S + nonessential amino acids + 12.5 mmol/L HEPES + 50 μg/mL cefazolin + 10 μg/mL ciprofloxacin + 2.5 μg/mL amphotericin B + 5 μmol/L ROCK inhibitor | Ovoid to cuboid shape polygonal cells; seldom multinucleated; forming compact monolayer with occasional multinucleated cells | 34 hours | 94 |
37 | KKU-452 | EHCCA | Spindle-shaped cells; seldom multinucleated; segregated and spread surround | 17 hours | |||||||
38 | 2018 | China | ICC-1 | IHCCA | Primary tumor | No digestion | — | — | — | — | 73 |
39 | ICC-2 | ||||||||||
40 | 2019 | Thailand | KKK-D049 | IHCCA | Xenograft | 1000 U/mL collagenase + 0.1 mg/mL DNase I, 3 hours | Stromal cells sequentially removed by partial trypsinization and mechanical removal | DMEM + 10% FBS + P/S | Epithelial-like cells; high nuclear to cytoplasmic ratio; tight clustering | — | 95 |
41 | KKK-D068 | Epithelial-like, polygonal and spindle-shaped cells; high nuclear to cytoplasmic ratio | — | ||||||||
42 | KKK-D131 | Epithelial-like, polygonal and spindle-shaped cells; high nuclear to cytoplasmic ratio | — | ||||||||
43 | KKK-D138 | Epithelial-like, polygonal and spindle-shaped cells; high nucleus-to-cytoplasm ratio | — | ||||||||
44 | 2021 | Italy | 82.3 | IHCCA | Xenograft | Collagenase 200 U/mL, 3 hours, 37°C | 10% FBS + P/S + gemcitabine | Monolayer, adherent, epithelial-like cells | 53 hours | 74 |
CCA, cholangiocarcinoma; DMEM, Dulbecco's modified Eagle's medium; DPBS, Dulbecco's phosphate-buffered saline; EGF, epidermal growth factor; EHCCA, extrahepatic cholangiocarcinoma; FBS, fetal bovine serum; IHCCA, intrahepatic cholangiocarcinoma; KFSM, keratinocyte serum free medium; MEM, minimal essential medium; PBS, phosphate-buffered saline; P/S, penicillin/streptomycin; ROCK, Rho-associated kinase.